Cyclosporine in pancreatitis


The aim of this study is to evaluate cyclosporine as a novel therapy for dogs with insulin-resistant diabetes mellitus and chronic pancreatitis. There is some evidence in the human literature that chronic pancreatitis may have an underlying immune-mediated etiology and anecdotally, cyclosporine has resulted in improved diabetic control in a dog with chronic pancreatitis as a cause of insulin resistance. Qualifying cases will receive Atopica free of charge for the trial period of six weeks. For more information please contact Dr. Tim Kretzschmar at tkretzschmar@cvm.tamu.edu